MedTrace Logo

Immunology of HIV and Alcoholic Hepatitis

NCT03951662 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-01-22

No results posted yet for this study

Summary

This is prospective, longitudinal cohort study involving HIV-positive, antiretroviral (ART)-treated, heavy alcohol drinking participants who have and do not have alcoholic hepatitis.

Conditions

Interventions

OTHER

Alcoholic Hepatitis Group

Alcoholic hepatitis is defined as having a total bilirubin level \>3mg/dL and AST level\>50U/L

OTHER

Heavy Drinking Controls without Hepatitis

Normal levels of AST, ALT and total bilirubin and without evidence of cirrhosis or hepatosplenomegaly

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03951662 on ClinicalTrials.gov